{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:42:28Z","timestamp":1759984948680,"version":"build-2065373602"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary biliary cholangitis (PBC) is an immune-mediated cholestatic liver disease with currently limited therapeutic options. This study aimed to identify novel therapeutic targets for PBC via systematic druggable genome-wide Mendelian randomization (MR) analysis, predict candidate drugs, and experimentally validate the candidates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study integrated druggable genome data, cis-expression quantitative trait loci (cis-eQTL) in blood and liver tissues, and summary data from PBC genome-wide association studies (GWAS). Two-sample MR analysis and colocalization analysis were used to screen genes significantly associated with PBC, followed by phenome-wide association study (PheWAS), functional enrichment analysis, protein-protein interaction (PPI) network construction, drug prediction, and molecular docking. Finally, the therapeutic potential of the candidate drug galangin (GAL) was validated using an \u03b1-naphthylisothiocyanate (ANIT)-induced PBC mouse model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 15 druggable genes significantly associated with PBC were identified, primarily enriched in biological processes regulating immune homeostasis, inflammatory signaling, and apoptosis, among others. Subsequent bioinformatic drug prediction and molecular docking identified GAL as a promising drug candidate, showing strong binding affinity to the target ADORA2A. Animal experiments showed that GAL reduced portal tract inflammation and bile duct hyperplasia in liver tissues, while reducing serum levels of liver enzymes (ALT, AST, ALP, etc.) and hepatic expression of inflammatory cytokines (IL-1\u03b2, IL-6, TNF-\u03b1).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>By integrating systematic druggable genome-wide MR analysis with experimental validation, this study identified 15 druggable genes associated with PBC. More importantly, it identified GAL as a therapeutic candidate for PBC, with its effects potentially mediated by the ADORA2A target. These findings provide novel therapeutic targets and drugs for PBC. Future research will focus on validating the functions of these druggable genes and elucidating the mechanistic pathway of the galangin-ADORA2A interaction, laying a more solid and comprehensive theoretical and practical foundation for PBC treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1674693","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:48Z","timestamp":1759983768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Weirui","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2013.03.115","article-title":"Adenosine A2A receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, PI3-kinase and ERK1\/2 pathways","volume":"434","author":"Ahmad","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/biom9080346","article-title":"Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity","volume":"9","author":"Aladaileh","year":"2019","journal-title":"Biomolecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101188","DOI":"10.1016\/j.xcrm.2023.101188","article-title":"Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma","volume":"4","author":"Allard","year":"2023","journal-title":"Cell Rep. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5152\/tjg.2023.22239","article-title":"Management of primary biliary cholangitis: current treatment and future perspectives","volume":"34","author":"Barba Bernal","year":"2023","journal-title":"Turk J. Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12935-024-03258-9","article-title":"Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75","volume":"24","author":"Cai","year":"2024","journal-title":"Cancer Cell Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0267624","DOI":"10.1371\/journal.pone.0267624","article-title":"Antioxidant properties of bee propolis and an important component, galangin, described by X-ray crystal structure, DFT-D and hydrodynamic voltammetry","volume":"17","author":"Caruso","year":"2022","journal-title":"PloS one"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103672","DOI":"10.1016\/j.etap.2021.103672","article-title":"Intrahepatic cholestasis induced by \u03b1-naphthylisothiocyanate can cause gut-liver axis disorders","volume":"86","author":"Chen","year":"2021","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/biomedicines13051022","article-title":"Identification of therapeutic targets for hyperuricemia: systematic genome-wide mendelian randomization and colocalization analysis","volume":"13","author":"Chen","year":"2025","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-015-0168-2","article-title":"Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC\/ERK signaling pathway in TPA-treated liver cancer HepG2 cells","volume":"15","author":"Chien","year":"2015","journal-title":"Cancer Cell Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.3390\/ijms252010997","article-title":"Molecular landscape of bladder cancer: key genes, transcription factors, and drug interactions","volume":"25","author":"Danishuddin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ Clin. Res. ed."},{"key":"B13","doi-asserted-by":"publisher","first-page":"106506","DOI":"10.1016\/j.jff.2024.106506","article-title":"Galangin alleviates alcoholic liver disease by regulating the gut-liver axis","volume":"122","author":"Duan","year":"2024","journal-title":"J. Funct. Foods."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1084\/jem.20161120","article-title":"Suppression of Th17 cell differentiation by misshapen\/NIK-related kinase MINK1","volume":"214","author":"Fu","year":"2017","journal-title":"J. Exp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1080\/15548627.2021.2016233","article-title":"AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability","volume":"18","author":"Ganapathy","year":"2022","journal-title":"Autophagy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-022-02296-2","article-title":"Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes","volume":"20","author":"Gautheron","year":"2022","journal-title":"BMC Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5114\/ceh.2025.148221","article-title":"1,400 genetically predicted plasma metabolites in relation to risk of primary biliary cholangitis: a bi-directional, two-sample Mendelian randomization analysis","volume":"11","author":"Geng","year":"2025","journal-title":"Clin. Exp. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cld.2022.06.002","article-title":"Genetics of primary biliary cholangitis","volume":"26","author":"Gerussi","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"127235","DOI":"10.1016\/j.jtemb.2023.127235","article-title":"Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: a review","volume":"79","author":"Hadrup","year":"2023","journal-title":"J. Trace Elem. Med. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9603271231164913","DOI":"10.1177\/09603271231164913","article-title":"Genistein attenuates renal ischemia-reperfusion injury via ADORA2A pathway","volume":"42","author":"He","year":"2023","journal-title":"Hum. Exp. Toxicol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.nucmedbio.2019.12.006","article-title":"Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis","author":"Higashikawa","year":"2020","journal-title":"Nucl. Med. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/nu10070892","article-title":"Celiac disease and liver disorders: from putative pathogenesis to clinical implications","volume":"10","author":"Hoffmanov\u00e1","year":"2018","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","first-page":"966759","DOI":"10.3389\/fphar.2022.966759","article-title":"Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0168-8278(03)00270-8","article-title":"Pathogenesis of primary biliary cirrhosis","volume":"39","author":"Jones","year":"2003","journal-title":"J. hepatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/gene.2013.1","article-title":"Pathway-based analysis of primary biliary cirrhosis genome-wide association studies","volume":"14","author":"Kar","year":"2013","journal-title":"Genes Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/itt.S494692","article-title":"Genetic and plasma proteomic approaches to identify therapeutic targets for Graves' Disease and Graves' ophthalmopathy","volume":"14","author":"Ke","year":"2025","journal-title":"Immunotargets Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"501739","DOI":"10.1155\/2009\/501739","article-title":"Regulation of bile acid and cholesterol metabolism by PPARs","volume":"2009","author":"Li","year":"2009","journal-title":"PPAR Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.3748\/wjg.v26.i31.4656","article-title":"Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors","volume":"26","author":"Li","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/schbul\/sbad100","article-title":"Mendelian randomization using the druggable genome reveals genetically supported drug targets for psychiatric disorders","volume":"49","author":"Li","year":"","journal-title":"Schizophr. Bull."},{"key":"B35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41420-023-01403-3","article-title":"The effects of MYC on tumor immunity and immunotherapy","volume":"9","author":"Li","year":"","journal-title":"Cell Death Discov."},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","article-title":"New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation","volume":"29","author":"Li","year":"2024","journal-title":"Cell Mol. Biol. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1074\/jbc.M807426200","article-title":"Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner","volume":"284","author":"Lichti-Kaiser","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jbmr\/zjae136","article-title":"Causal inference in health and disease: a review of the principles and applications of Mendelian randomization","volume":"39","author":"Lovegrove","year":"2024","journal-title":"J. Bone Min. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12944-025-02515-8","article-title":"Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Ma","year":"2025","journal-title":"Lipids Health Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.21608\/besps.2021.90723.1109","article-title":"Selenium attenuates cholestasis-induced liver injury and fibrosis by alleviating liver oxidative stress and inflammation in rats","volume":"42","author":"Nassef","year":"2021","journal-title":"BEMACS"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e002591","DOI":"10.1136\/jitc-2021-002591","article-title":"Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies","volume":"9","author":"Nishikawa","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0247","article-title":"Disease-modifying therapies and symptomatic management for primary biliary cholangitis","volume":"82","author":"Patel","year":"2021","journal-title":"Br. J. Hosp. Med. (Lond)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0032","article-title":"Ethnomedical potentials, phytochemicals, and medicinal profile of Alpinia galanga L. a comprehensive review","volume":"5","author":"Priyono","year":"2024","journal-title":"BIO Integr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"19477","DOI":"10.1038\/s41598-023-46521-1","article-title":"ADORA2A promotes proliferation and inhibits apoptosis through PI3K\/AKT pathway activation in colorectal carcinoma","volume":"13","author":"Ran","year":"2023","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/jhrs.jhrs_44_24","article-title":"Identification of key genes associated with polycystic ovarian syndrome and endometrial and ovarian cancer through bioinformatics","volume":"17","author":"Raulo","year":"2024","journal-title":"J. Hum. Reprod. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/0002-9343(60)90161-3","article-title":"Intrahepatic cholestasis following administration of chlorpropamide: report of a case with electron microscopic observations","volume":"28","author":"Reichel","year":"1960","journal-title":"Am. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.semarthrit.2007.10.002","article-title":"Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis","volume":"38","author":"Satpute","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/molecules30061253","article-title":"Preventive and therapeutic effects of Baicalein, galangin, and Isorhamnetin in chronic liver diseases: a narrative review","volume":"30","author":"Scarlata","year":"2025","journal-title":"Molecules"},{"key":"B50","first-page":"721","article-title":"Chlorpropamide hepatotoxicity: report of a case and review of the literature","volume":"79","author":"Schneider","year":"1984","journal-title":"Am. J. Gastroenterol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.ajhg.2025.06.014","article-title":"Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction","volume":"112","author":"Seagle","year":"2025","journal-title":"Am. J. Hum. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/s0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"155944","DOI":"10.1016\/j.phymed.2024.155944","article-title":"Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT\/BCL-6\/ABCA1 axis","volume":"133","author":"Song","year":"2024","journal-title":"Phytomedicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"611610","DOI":"10.3389\/fphar.2021.611610","article-title":"Effect of different ratios of Yinchen and Gancao decoction on ANIT-Treated cholestatic liver injury in mice and its potential underlying mechanism","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease","volume":"94","author":"Su","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-024-01828-w","article-title":"Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine","volume":"25","author":"Sun","year":"","journal-title":"J. Headache Pain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12929-024-01052-3","article-title":"Cholestasis-induced phenotypic transformation of neutrophils contributes to immune escape of colorectal cancer liver metastasis","volume":"31","author":"Sun","year":"","journal-title":"J. Biomed. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/1547691x.2021.1890863","article-title":"Galangin ameliorates experimental autoimmune encephalomyelitis in mice via modulation of cellular immunity","volume":"18","author":"Tan","year":"2021","journal-title":"J. Immunotoxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hep.510310204","article-title":"Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis","volume":"31","author":"Tjandra","year":"2000","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12967-025-06366-w","article-title":"Multi-omic studies on the pathogenesis of Sepsis","volume":"23","author":"Tong","year":"2025","journal-title":"J. Transl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s40572-018-0213-0","article-title":"Environmental Selenium and human health: an update","volume":"5","author":"Vinceti","year":"2018","journal-title":"Curr. Environ. Health Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.etap.2013.04.004","article-title":"Antifibrotic activity of galangin, a novel function evaluated in animal liver fibrosis model","volume":"36","author":"Wang","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B65","first-page":"8742","article-title":"Galangin attenuates IL-1\u03b2-induced catabolism in mouse chondrocytes and ameliorates murine osteoarthritis","volume":"13","author":"Wang","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1150879","DOI":"10.3389\/fimmu.2023.1150879","article-title":"Inflammasome and pyroptosis in autoimmune liver diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jgg.2023.05.013","article-title":"Zebrafish ppp1r21 mutant as a model for the study of primary biliary cholangitis","volume":"50","author":"Wu","year":"2023","journal-title":"J. Genet. Genomics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00403-024-03331-3","article-title":"Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study","volume":"316","author":"Wu","year":"2024","journal-title":"Arch. Dermatol Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1589388","DOI":"10.1155\/2022\/1589388","article-title":"Mechanism and active components of qingre Lidan tablets alleviate intrahepatic cholestasis by activating the Farnesoid X receptor","volume":"2022","author":"Xia","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13098-025-01710-y","article-title":"Identifying therapeutic target genes for diabetic retinopathy using systematic druggable genome-wide Mendelian randomization","volume":"17","author":"Xie","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1038\/s41598-025-94303-8","article-title":"Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction","volume":"15","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e826","DOI":"10.1002\/iid3.826","article-title":"Role of adenosine A2a receptor in cancers and autoimmune diseases","volume":"11","author":"Ye","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/jcsm.13479","article-title":"Systematic druggable genome\u2010wide Mendelian randomization identifies therapeutic targets for sarcopenia","volume":"15","author":"Yin","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1038\/s41467-025-58248-w","article-title":"A genome-wide cross-trait analysis characterizes the shared genetic architecture between lung and gastrointestinal diseases","volume":"16","author":"You","year":"2025","journal-title":"Nat. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.2147\/dddt.S258187","article-title":"Galangin improved non-alcoholic fatty liver disease in mice by promoting autophagy","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10194-024-01805-3","article-title":"Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization","volume":"25","author":"Zhang","year":"2024","journal-title":"J. Headache Pain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2147\/dddt.S362238","article-title":"The extract of Ilex cornuta Bark promotes bone healing by activating adenosine A2A receptor","volume":"16","author":"Zheng","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"959074","DOI":"10.3389\/fphar.2022.959074","article-title":"Targeted bile acid profiles reveal the liver injury amelioration of da-chai-hu decoction against ANIT- and BDL-induced cholestasis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.62347\/BTYN8678","article-title":"CDC42: unlocking a novel therapeutic target for primary sclerosing cholangitis through Mendelian randomization","volume":"17","author":"Zhou","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"12227","DOI":"10.1038\/srep12227","article-title":"Computational prediction and validation of BAHD1 as a novel molecule for UlcerativeColitis","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1674693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:50Z","timestamp":1759983770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1674693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":80,"alternative-id":["10.3389\/fphar.2025.1674693"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1674693","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"article-number":"1674693"}}